Childhood vaccination. Pre-empt the diseases that historically killed infants.
It is a product you buy.
It exists to relieve Keep a fragile newborn alive. That is the whole reason it is here: nothing enters this map without a human problem behind it.
It could not exist without Vaccine science and Pediatric care. These are the quiet preconditions — remove any one and the solution stops working.
Solving that problem created new ones: Parents cannot evaluate the risk they are told to accept. Follow those and you find the next generation of products built on top of this one.
8 organisations in this map sell it, 8 of them publicly listed.
Its neighbourhood
Everything this entry connects to directly. Click any point to follow it.
The line back to a human being
2 hops from a person at a phase of life. The further a thing sits from the person, the more abstract it looks — and the more it tends to be mistaken for something that came from nowhere.
- SolutionChildhood vaccination
- FrictionKeep a fragile newborn alive
- Life phaseInfancy
- Rooted inMortality
- Rooted inSafety
Relieves
Created these new problems
Second-order frictions. This is where most of the modern economy actually lives.
Requires
Who sells it
| Organisation | Value | Type | Products |
|---|---|---|---|
| AstraZeneca | $230B | public · AZN | oncology, Farxiga, vaccines |
| Merck | $220B | public · MRK | Gardasil, MMR-II, Keytruda |
| Pfizer | $150B | public · PFE | Prevnar vaccines, Comirnaty, Eliquis |
| Sanofi | $120B | public · SAN | Dupixent, vaccines, Beyfortus infant RSV |
| CSL | $80B | public · CSL | plasma therapies, flu vaccines |
| GSK | $75B | public · GSK | Shingrix, Arexvy, HIV medicines |
| Takeda | $45B | public · TAK | rare disease, vaccines, plasma |
| Moderna | $12B | public · MRNA | mRNA vaccines, cancer vaccine pipeline |